ResMed Inc (RMD)

Pretax margin

		Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Earnings before tax but after interest (EBT)	US$ in thousands	1,264,800	1,101,660	960,483	883,662	733,088
Revenue	US$ in thousands	4,681,150	4,175,350	3,649,870	3,265,510	2,957,010
Pretax margin		27.02%	26.38%	26.32%	27.06%	24.79%

June 30, 2024 calculation

Pretax margin = EBT ÷ Revenue
= $1,264,800K ÷ $4,681,150K
= 27.02%

The pretax margin of ResMed Inc has shown a relatively stable trend over the past five years, ranging from 24.79% in June 2020 to 27.06% in June 2021. In the most recent fiscal year ending June 30, 2024, the pretax margin improved to 27.02%. This indicates that the company has been effective in managing its operating expenses and generating operating income relative to its revenue. Overall, ResMed Inc has demonstrated consistent profitability before accounting for taxes over the analyzed period.